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The burden of rare diseases: A systemaic review of the specific problems and 
needs unique to patients with rare diseases and their families 
Abstract 
Purpose: The true challenges faced by patients with rare diseases (RDs) in their daily lives 
remain relatively unknown.  This review aims to systematically investigate and describe what is 
known about the problems and needs of patients with RDs and the impacts of these issues in 
their daily lives. 
Methods: A systematic review was undertaken using an electronic data base and research 
articles published after 2005.  Eligible studies included those containing information relating to 
patients with RD and problems, needs, and/or impacts they faced in daily life.  In all, a total of 
27 studies were selected. 
Results:  Patients with RDs and their families face multiple challenges in their daily lives.  They 
have problems concerning difficulty obtaining accurate and timely diagnoses, the detrimental 
effects of lack of physician knowledge, patient-physician role discrepancies, increased needs and 
use of health services, lack of adequate social services supports, and lack of treatment options 
and medications.  They also have information needs, peer-support needs, and the need of patient 
support groups because of both the information and social support they can provide.  In daily live 
they are impacted in a number of ways such as decreased quality of life (QoL), adverse impacts 
on daily life, negative effects on psychosocial health, and an overall significant impact on the 
family as a unit. 
Conclusion:  Patients with RDs face a tremendous amount of struggles and challenges in daily 
life.  With a better understanding of these issues and subsequent policy changes, more 
comprehensive health care and social support may be provided to them such that the burden 
presented by RDs can be reduced. 
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Introduction 
Navigating life with a rare disease (RD) presents a special host of challenges that go 
above and beyond that of life with a more common chronic disease.  The severity of symptoms 
of these diseases ranges from mild to severe and they are commonly chronic, genetic disorders.  
Rare diseases (RDs) often affect life expectancy, impair physical and mental abilities, and may 
be severely disabling (Scieppati, Henter, Daina, & Aperia, 2008).  The complexity of living with 
a RD includes many more facets than obtaining medical care alone and patients with RDs 
struggle daily with issues that include physical, psychological, social, financial, informational, 
and organizational domains, among others.  The impacts of RDs have been studied in a number 
of countries, but the implications of living with a RD are still often misunderstood and the 
problems and needs of patients and their families under-recognized (Landfeldt, Lindgren, Bell, 
Schmitt, Guglieri, Straub, et al., 2014).  Many of these obstacles patients with RDs face are 
critical determinants of health, putting them at risk of health disparities, thus they are important 
topics of study (Dwyer, Quinton, Morin, & Pitteloud, 2014). 
RDs present a significant burden to patients, their families, and society as collectively 
they are common despite being individually rare.  In the U.S. the definition of RD is one that 
affects fewer than 200,000 Americans at any given time and in Europe, RDs are defined as those 
that affect less than 1 in 2000.  In both the U.S and Europe there are thought to be about 30 
million (i.e. 60 million total) patients suffering from RDs and there are over 6,000 different RDs 
currently known and documented by the NIH (EURORDIS, 2015; NORD, 2015).  Important to 
remember however is that the true incidence of RDs may be hard to ascertain, as many go 
undiagnosed, and estimates vary per disease and region.   
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Because of their rarity, there exists a dearth of knowledge, understanding, and 
recognition about the true implications of a rare diagnosis and the resulting problems and needs 
it presents for patients and their families (Landfeldt, et al., 2014; Wallenius, Möller, & Berglund, 
2009).  In order to provide adequate and appropriate healthcare with a holistic focus for these 
patients, the problems and needs specific to patients with RDs needs to be further investigated 
and addressed.  The purpose of this study is to describe what is known about the challenges 
patients with RDs experience and explore the various problems and needs they encounter, and 
resultant impacts in their daily life. 
Literature Search Methods 
 A systematic search of the literature was performed to find articles relevant to the 
problems, needs, and impacts of RD on patients and their families.  CINAHL and PubMed 
databases were used.  Five Boolean searches were performed using the terms ["rare disease*" 
and (patient*) and (impact* or need* or problem*)], [rare and (disorder OR disease) and (support 
or advoca*)], [internet and rare and (disease or disorder)], [(rare or orphan) (disease* or 
disorder* or ill*) and patient* and (impact* or need* or problem*)], and ["rare disease*" and 
patient and (support or advoca*) and group].  Inclusion criteria consisted of research articles on 
the subject of RDs meeting the NORD definition of RD.  They had to be in English, published in 
2005 or later, and be relevant to problems, needs, and/or impacts patients of RDs are challenged 
with.  Articles not meeting the inclusion criteria were excluded (conference reports, meeting 
abstracts and editorials; non-English articles; those published prior to 2005; articles regarding 
symptoms of specific rare disorders as these are less likely to be shared universally among RDs).  
In the case of multiple articles within one RD and about similar themes, the most current and 
encompassing article was chosen.  The literature search yielded 1563 articles of which 62 were 
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potentially relevant based on the title and description alone.  Following a review of the papers’ 
abstracts, 36 articles were excluded, and following further evaluation of the articles’ contents 6 
more articles were excluded.  A hand search of the articles’ references was performed for 
supplemental publications which produced an additional 7 articles for a total of 27 relevant 
articles.  The flow of selection of literature is depicted in Figure 1. 
Results 
 Twenty-seven studies containing topics relevant to the problems, needs, and/or impacts 
of RDs on patients and/or their families were identified in the systematic search of the literature.  
Qualitative studies comprised 10 of the studies, 7 were quantitative studies, and 10 were of 
mixed methods.  Twenty five studies were cross sectional, 2 longitudinal, and 3 were literature 
reviews.  The 27 studies came from 13 countries, including 3 international studies.  The number 
of articles and countries represented include 1 Austrialian article, 1 Canadian, 1 Danish, 2 
European, 1 French, 2 German, 1 Italian, 1 Norwegian, 2 Spanish, 2 Swedish, 1 Swiss, 6 
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Figure 1. Flow Diagram of study selection process.  
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Problems Experienced by Patients with RDs 
Difficulty Obtaining Timely, Accurate Diagnoses 
The delay in diagnosis and multiple misdiagnoses that patients with RD experience was 
the most common problem expressed in this set of publications.  Eleven of the 27 papers 
discussed this issue, its prevalence, and its implications.  In the Australian study of children with 
genetic metabolic disorders, 17% had received a wrong, initial diagnosis, 38% of children had 
seen 3-5 doctors, and 14% had seen 6-10 before receiving the correct diagnosis.  Almost half 
(43%) of these parents believed that diagnosis could be made earlier (Anderson, Elliott, & 
Zurynski, 2013). On average, adult patients with Hereditary Angioedema (HAE) reported seeing 
4 different physicians over 8 years before receiving an accurate diagnosis and their rate of 
misdiagnosis was found to be a high 65%.  Other sequelae such as unnecessary treatments, 
surgical procedures, and even premature death had resulted from this due to HAE’s under 
recognition and the misdiagnoses (Banerji, et al., 2013).  Pediatric patients with HAE had similar 
rates of misdiagnoses with 8 of 16 UK centers that treated it reporting their patients had been 
previously misdiagnosed.  Different from adult HAE patients however, the pediatric patients, 
generally had a shorter average time to diagnosis as patients with a family history were routinely 
tested at 12 months of age (Read, Lim, Tarzi, Hildick-Smith, Burns, & Fidler,, 2014).  At least 
one misdiagnosis was reported by 44% of Familial Cold Autoinflammatory Syndrome (FCAS) 
patients (Stych, & Dobrovolny, 2008) and a prominent theme with Neuroendocrine Tumor 
(NET) patients in the qualitative study by Feinberg, Law, Singh, & Wright was the difficulty in 
obtaining a diagnosis (2013). 
Publications considering multiple RDs found similar rates and themes of delays and 
misdiagnoses.  In the US, 33% of RD patients remained undiagnosed for more than a year 
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(Zurynski, Frith, Leonard, & Elliott, 2008) and in Europe 25% of patients had to wait between 5 
and 30 years from the start of early symptoms until receiving a diagnosis of their RD 
(EURORDIS, 2007). In Norway, 50% of parents of children with RDs waited 1-3 years for a 
diagnosis (Gundersen, 2011) and in Sweden 17% of patients with RD reported at least one 
misdiagnosis (Wallenius et al., 2009).  Furthermore, in Europe, 40% of RD patients received a 
misdiagnosis the first time, while others received no diagnosis, and some of these misdiagnoses 
resulted in erroneous medical interventions and surgeries based upon them.  25% of European 
patients with RDs had to travel to a different region to receive a proper diagnosis and 2% had to 
travel to a different country.  The way in which European patients with RDs’ diagnoses were 
announced was found to unsatisfactory by 33% and unacceptable by 12.5% (EURORDIS, 2007).  
However the findings from the Australian study showed 77% of parents being satisfied with the 
way in which they were informed of diagnosis, even with feelings of ‘shock,’ ‘confusion,’ and 
‘heartbrokenness,’ and no psychological support or counseling offered at diagnosis (Anderson, et 
al., 2013).  In Europe, despite the genetic origin of RDs, 25% of European patients felt that this 
was not communicated with only 50% of these patients receiving genetic counseling 
(EURORDIS, 2007). 
The importance and need of having a diagnosis was another relevant theme expressed by 
parents in Gundersen’s findings.  Parents felt that not having a diagnosis caused them to 
experience more stress and isolation and that they had more difficulty accepting their child’s 
challenges than without it (Gundersen, 2011).  Among parents of Ectodermal Dysplasia (ED) 
patients, an early diagnosis was found to be highly important with nearly all parents in the study 
wanting this.  They felt it offered advantages in the care of their children such as managing and 
providing appropriate care; accessing support, resources, and treatments; answering questions, 
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peace of mind, reducing concerns, and planning for the future.  The most common sentiment 
expressed by these parents to the diagnosis was ‘relief’ (Pelentsov, O'Shaughnessy, 'Kevin', 
Laws, & Esterman, 2014).  Overall, as found to be a theme in Limb, Nutt, and Sen’s study, a 
large number of patients and families wait far too long to receive a diagnosis for their RD and 
this wait has far reaching implications (2010). 
Lack of Physician Knowledge & Expertise 
 As noted in a study examining children with Rare Intellectual Disorders (RIDs) where 
mothers felt the lack of physician expertise contributed to delays in the diagnosis and treatment 
of their children (Griffith, Hastings, Nash, Petalas, Oliver, & Howlin, 2011).  Lack of knowledge 
by physicians with regards to RDs was another prominent issue raised by 10 articles in the series.  
The level of awareness and knowledge of RDs among health care professionals is a considerable 
worry for these patients and families (Limb, et al., 2010) and results in inadequate care.  
Anderson, et al., found that 43% of parents in their study believed this is what delayed their 
child’s diagnosis (2013).  For 1660 RD patients in Sweden, the lack of knowledge regarding 
their diagnoses resulted in maltreatment for 32% and negative treatment or not being 
acknowledge for 26% of patients (Wallenius, et al., 2009).  NET patients had difficulty finding 
appropriate information about NETs from physicians (Feinberg, et al., 2013) and 67% of 
Congenital Hypogonadotropic hypogonadism (CHH) patients perceived that their health care 
provider understood the medical aspects of their condition while only 38% perceived they 
understood the emotional aspects (Dwyer, et al, 2014). 
 Budych, Helms, & Schultz found that the insufficient expertise of health care providers 
proved to be a major issue in the specialized treatment of RDs (2012).  Further, Limb et al., 
found that while some patients are informed of off-label medications and treatments, many RD 
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patients and families have to inform their doctors of them (2010).  A problem with RDs is that 
they often do not have standardized diagnostic criteria and it results in multiple, often 
unavoidable, inquiries.  In Australia, only 19% of pediatricians knew the diagnostic criteria for 
Fetal Alcohol Syndrome (FAS), complicated by the notion that 70% of them had concerns that 
making the diagnosis would stigmatize the child.  After a diagnosis, the lack of management 
guidelines, referral pathways, and services are other challenges for physicians treating patients 
with RDs (Zurynski, et al., 2008). 
 For patients with HAE, Banerji found that lack of awareness of HAE to the broader 
medical community was a barrier to early diagnosis (2013).  Primary care, family physicians, GI 
doctors, dermatologists and emergency department physicians were all considered participants in 
the care of HAE patients who would benefit from increased physician education (re: HAE) and 
the development and dissemination of HAE treatment guidelines.  Also brought to light was the 
fact that the HAE management guidelines had not been updated by the American Academy of 
Emergency Physicians since 2006 (emergency department physicians commonly see these 
patients during exacerbations) despite newer, more effective, treatments being available in the 
US as recently as 2008 and 2009, and that only 1.2% of the total articles on HAE that came back 
in Banerji’s literature search were published in emergency medicine journals (2013). 
 From the point of view of physicians, primary care doctors and pediatricians believe there 
is insufficient awareness about RDs and would like access to more evidence based information 
for both themselves and patients about RD diagnoses, management, and specialized referral 
centers (Zurynkski, et al., 2008).  Unfortunately, the culmination of this lack of physician 
knowledge, expertise, and awareness about RDs, and the subsequent delays in diagnosing and 
testing, creates a lack of trust for RD patients in health care providers.  This same sentiment was 
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echoed in the theme of the chat room content of an online Alpha-1 patient support group 
(Holtzclaw-Williams, Finn, & Strange, 2013). 
Patient-Physician Role Discrepancies 
 With RDs, role discrepancies occur as a result of the patient becoming the ‘expert’ on the 
RD, when traditionally the healthcare provider is considered the expert on health disorders.  The 
typical physician-patient relationship is often disrupted which has a major impact on 
communication processes as in this context, communication is affected by the role behavior of 
both the patient and provider.  The patient however is forced to assume the role of the expert 
because of the lack of knowledge of physicians on RDs and the limited therapeutic options 
available for treatment (Budych, et al., 2012).  In Pelentsov, et al.’s 2014 study of ED patients, 
although 53% were satisfied with the level of support they received from specialists, 75% 
reported they would have liked even more support and oftentimes patients take it upon 
themselves to search for information not available from doctors.  Thus, a patient-directed 
physician interaction is a widely experienced pattern of communication for patients with RDs 
(Budych, et al., 2012).  Because the vast majority of patients with RDs actively seek information 
about their disease, it is more effective for healthcare providers to help promote the patient’s 
awareness of their illness and for policy makers to support their need of seeking information and 
accessing specialists.  Budych et al.’s study showed relevance to a provider’s ability to 
acknowledge the patient’s roles as an informed, involved, and interactive partner in the disease 
process and that a majority of physicians acted as the patient’s partner in the medical encounter.  
However, a minority of physicians stills rejected the patient’s assertive behavior and were 
arrogant to the patient.  Thus, allowing the patient to control therapy would require a change of 
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mind-set considering the traditional roles in health care, but the need is clearly evident (Budych, 
et al., 2012) 
Increased Health Services Needs 
 Like many chronic diseases, patients with RDs have a high usage of medical services and 
five of the articles explored this need for health services.  In the Australian study of children with 
metabolic disorders, 53% reported between 1 and 3 hospital admissions in the last year with 13% 
having 4 or more.  There was an average of 7 visits per child per year to the general practitioner 
8 visits per child per year to specialists, and 11 visits per child per year to allied health specialists 
such as physical therapy, occupational therapy, or speech therapy (Anderson, et al., 2013).  
Systemic Sclerosis (SS) patients had an average of 14 medical tests, 44 medical visits (mostly 
physical therapy), and 1.6 hospitalizations with a 5-day length of stay per year (Chevreul, 
Brigham, Gandre, & Mouthon,2014).  Adults with Hemophilia (HM) averaged 3.89 specialist 
visits over 6 months, while children with the same condition averaged 2.04 (Kodra, Cavazza, 
Schieppati, De Santis, Armeni, & Arcieri, 2014).  Those with Rett syndrome averaged 9 medical 
appointments per year, 33% of patients in the study required hospitalization and 66% attended 
regular therapy sessions in the past year (Zurynski, et al., 2008).  In comparison with control 
individuals with more common diagnoses, Marfan Syndrome (MFS) patients had 39% more 
physician contacts, a 153% longer length of hospital stay, 119% more inpatient stays, 33% more 
prescriptions, and 236% more medical imaging (Achelrod, Blankart, Linder, von Kodolitsch, & 
Stargardt, 2014). 
Barriers to Accessing Health Services 
 With RDs, patients and their families encounter a number of barriers in their attempts to 
get adequate and appropriate health care in order to properly care for their disease.  Eight of the 
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articles explored these issues.  50% of the patients with RDs in Wallenius et al.’s study reported 
problems with primary care, 25% being considerable problems, and 33% reporting minor to very 
big problems with specialist care (2009).  The mothers of children with RIDs had largely 
negative experiences with health care professionals.  Half of these mothers reported a form of 
prejudice against their child’s intellectual disability and attributed the lack of physician 
knowledge to difficulties in obtaining health care because they could not give specific medical 
advice (Griffith, et al., 2011).  Overall, patients with RDs from Kodra, Morosini, Petrigliano, 
Agazio, Salerno, & Taruscio’s 2007 study felt that health care accessibility was worse than 
quality. 
Issues with travel distances, care coordination, medication/treatment access, and 
availability of treatment centers were other problems.  Limb et al.’s study found that there was a 
lack of health services support for patients with RDs, that the majority of care is poorly 
coordinated, patients must attend various clinics for different aspects of their condition and often 
have to travel long distances from where they live, and that the majority of patients do not have 
access to a specialist center for their condition.  Also, that it was distressing to attempt to obtain 
medications and there are inconsistencies with access to them, complicated by the fact that there 
is no licensed treatment available for many patients with RD (2010).  Anderson et al.’s study also 
found issues with equitable access to treatments (2013) and patients with RIDs reported uneven 
medical and social care provisions (Griffith, et al., 2011).  For pediatric patients with HAE, Read 
et al. found that they did not have the same level of access to care, in terms of home therapy 
(62% had home therapy), as adults despite it being emphasized in treatment guidelines and being 
shown to improve the quality of life for both the patient and family, and that in the UK, only 2 of 
16 specialized medical centers had designated HAE clinics, however 9 of 16 had HAE protocols 
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(2014).  For those with CHH, only 51% had been seen at a specialized or academic medical 
center (Dwyer, et al., 2014). In the literature review by Zurynski et al., almost half of patients 
with RDs in the US had to travel over 50 miles to access appropriate medical services with 26% 
finding it difficult or all together impossible to access medical services and that the transition 
from pediatric to adult health services was reported to be a significant problem (2008).    
Anderson et al.’s 2013 study also found that distance to travel (43% of patients reported this) 
was a significant impediment to accessing health services, as was the need for sibling care, cost 
of services, lack of available services, lost time from work, lack of referrals, and long waits to 
see the specialists or other doctors.  These same parents had ideas about ways to improve health 
services reporting at a rate of 93% that an electronic health record would improve their 
experience of accessing health care.  73% also believed that the role of the General Practitioner 
(GP) should be to coordinate services and 77% thought that accessing health services through a 
specialized center housing multidisciplinary services improved or would improve their 
experience of accessing health care (Anderson, et al., 2013). 
Lack of Adequate Social Services Support & Accessibility 
 Dealing with social services was another adversity for patients with RDs to overcome 
that surfaced in 3 of the articles.  The 600 patient cohort (UK) in Limb et al.’s study reported a 
lack of social services support for RD patients (2010) while the 89 (Italian) patients from Kodra 
et al.’s study thought that social and legal provisions were worse than health care (2007).  More 
specific issues were explored by Griffith et al.   These include the inertia of social care services, 
the complexity of the systems, and that mothers had to work exceedingly hard to make sure the 
needs of their offspring (adult child) were met (2011).  Additionally, pervasive problems were 
reported with day, respite, and residential services because of frequent staff turnover and which 
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resulted in mistrust of these workers by the mothers.  Two of eight mothers (25%) reported 
physical abuse of their child from care workers and only one was completely satisfied with her 
offspring’s residential placement which was at a center with a low turnover rate (Griffith, et al., 
2011).  ‘Mothers as advocates’ was a central theme expressed in dealing with social services, 
with mothers often referring to interactions as ‘fights’ with a sense of ‘us vs. them.’  Mothers had 
to be persistent and did not feel they could rely on anyone else to obtain acceptable services for 
the children.  Seven of eight mothers had to obtain the help of higher authorities within the 
system in order to secure suitable services.  The negative psychological impact of these 
frustrations dealing with social services on physical and mental health was apparent in the 
interviews conducted in Griffith et al.’s study.  Mothers reported the stress of advocating for 
their offspring with social services attributed to high blood pressure and/or nervous breakdowns 
as a result of the additional burden of always making sure their offspring was being cared for 
appropriately (Griffith, et al., 2011). 
Increased Cost of Care and Supports 
 Ten of the studies examined in this review looked at the costs associated with RDs and 
found them to be exceedingly high.  Placing these costs into the following categories will allow 
consistency in evaluating the articles of this review.  “Direct medical costs” include hospital 
admissions, emergency visits, outpatient care (GPs and specialists), care by non-physicians (PT, 
OT, speech therapy, etc.), medical tests and examinations, pharmaceuticals, devices/medical 
appliances, rehabilitation, and medical home-care services.  “Direct non-medical costs” include 
caretakers/caregivers (formal and informal), administration costs, sick leave compensation, travel 
expenses for medical appointments, and ambulance transport.  Informal care is defined as tasks 
carried out by non-professionals that help to maintain or enhance patient independence and is 
16 
THE BURDEN OF RARE DISEASES 
typically provided by family, friends, or neighbors who are unpaid yet take on a deficit in terms 
of indirect costs in order to perform these tasks.  Lastly, indirect costs are comprised of the cost 
of absence from work, of premature death, of reduced work productivity, and of early retirement. 
Annually, the average patient with MFS generates an excess cost of €2,496 in 
comparison to a control group of more common disorders.  The strongest drivers of cost were 
related to inpatient treatment and care by non-physicians with ages 0-16 and 25-41 being the 
most expensive for this group.  Patients with MFS were also found to have 20% higher 
prescription costs than control individuals (Achelrod, et al., 2014).  Patients with Systemic 
Sclerosis (SS) had an average annual cost of €22,459 per patient with 47% coming from indirect 
costs and 38% from direct medical costs.  Direct medical costs were €8,452 of which 
hospitalizations represented 60%, while direct non-medical costs constituted €3,481 and came 
from both formal and informal caregivers and social services.  The high level of €10,526 in 
indirect costs came 77% from wages lost because of early retirement (Chevreul, et al., 2014).  
For patients with HM, the mean total annual cost per patient in 2012 was €117,732 and 92% of 
this came from medications.  Direct non-medical costs represented 4.4% of the total costs for 
patients with HM and the authors noted that costs other than medications for the HM population 
follow the same trend as the general population in that they are the highest in the first years of 
life and then decrease up to about age 46, when they start to increase again (Kodra, et al., 2014).  
Patients with Spinocerebellar Ataxia (SCA) had an estimated mean annual cost per patient of 
€18,776, with the most important categories of cost coming from coming from informal care, 
early retirement (from permanent disability), medications, and orthopedic devices.  Patients in 
the high severity group had 11% of total costs resulting from direct medical costs, 59% from 
direct non-medical costs, and 30% from indirect costs, while patients in the low severity group 
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had 20% of total costs resulting from direct medical costs, 3% from direct non-medical, and 77% 
from indirect costs.  Medications were the most important category of direct medical costs, and 
the 84 hours per week of primary caregiver services as well as 33 hours per week of secondary 
caregiver services required by the high severity group made up the bulk of the associated direct 
non-medical costs for this group (Lopez-Bastida, Perestelo-Perez, Monton-Alvarez, & Serrano-
Aguilar, 2008).  Patients with Amyotrophic Lateral Sclerosis (ALS) had similar cost partitioning 
as patients with SCA, however their mean annual cost per patient was higher at €36,194.  
Similarly to patients with SCA, the most important categories of costs came from informal care, 
early retirement (from permanent disability), medications, and orthopedic devices.  Patients in 
the high severity group had 21% of total costs from direct medical costs, 60% from direct non-
medical costs, and 19% from indirect costs, while patients in the lower severity group had 38% 
of total costs from direct medical costs, 1% from direct non-medical costs, and 61% from 
indirect costs.  The most import costs of the higher severity group came from the average 130 
hours per week of primary caregiver and 67 hours per week of secondary caregiver services 
required to care for patients with ALS (Lopez-Bastida, Perestelo-Perez, Monton-Alvarez, 
Serrano-Aguilar, & Alfonso-Sanchez, 2009).  Patients with HAE accrue an average annual cost 
of about $42,000 with 67% of this coming from hospital costs (Read, et al., 2014) and the 
annual, per patient, direct cost of illness for patients with Duchenne Muscular Dystrophy (DMD) 
in 2012 was found to be between $23,920 and $54,270 international dollars which is 7-16 times 
higher than the mean per-capita health expenditures in these countries (Landfeldt, et al., 2014). 
 The costs associated with illness related to RDs in two of the studies reviewed was not 
put into the same categories mentioned above, but nonetheless found to be high.  Patients in the 
U.S. with FAS were found to have total lifetime costs estimated at $2.9 million.  Other important 
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considerations brought up this study were that the costs of educating the average student with 
disabilities is double the amount required to educate a child without special needs and that the 
costs of raising a child with a RD are significantly higher than that of a healthy child.  The costs 
accrued in raising such a child come from specialized medical care, allied health services, 
educational services, specialized equipment, travel, and partial or total loss of income for the 
primary caregiver.  Higher costs of care are a result of patients with RDs needing to see multiple 
health professionals, specialized services, diagnostic investigations, equipment, therapies and 
orphan drugs (Zurynski, et al., 2008).  In Sweden, where the Social Insurance of Sweden covers 
most of health care costs, Wallenius et al. found that the extra costs attributable to RDs was 
€100/month for 15% of study participants, €20-€100 for 36%, and less than €20 for the 
remaining 49% of study participants (2009). 
 Because many patients with RDs require caregivers and/or experience disabilities, 
indirect costs were found to be a substantial portion of expenses related to RDs in the literature, 
while household burden and the need for financial assistance were other relevant topics.  In the 
study by Kodra, et al., 34% of patients with HM felt their labor productivity had decreased in the 
past 6 months, with patients also reporting an average of 38 days of sick leave and an average of 
2 hours less work per day.  58% of retired patients with HM had retired earlier than expected.  
Caregivers of these patients lost an average of 78 working days in the previous 6 months and 4 
hours daily, which equated to the average loss of productivity being around €2,740.  Lost 
productivity of adult patients with HM and lost productivity of caregivers (parents) related to the 
informal care they provide were the biggest cost drivers in this study (Kodra, et al., 2014).  In the 
study evaluating patients with DMD, indirect costs attributed to a substantial 18% - 43% of total 
costs and 27-49% of caregivers had reduced working hours or had stopped working as a result of 
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their child’s DMD diagnosis.  The caregivers who did work had a reported lost productivity of 1 
day out of 5 in a week.  Furthermore, the household burden of DMD was estimated to be 
$58,440-$71,900 and included income loss, monetary value of lost leisure time and reduced 
QoL, and the out of pocket costs of care (Landfeldt, et al., 2014).  78% of patients with FCAS 
reported a loss of productivity at work that included being late, having to leave early, working 
from home, and missed opportunities for job advancement, and 37% of these patients reported 
having to quit a job as a result of their disease (Stych, et al., 2008).  Parents of patients with ED 
reported that 29% of them had experienced an impact on their or their partner’s employment 
status as a result of having a child with ED (Pelentsov, et al., 2014).  In relation to financial 
assistance for patients with RDs, the Australian article found that despite 77% of parents 
receiving financial support for their child’s rare metabolic disorder, 52% thought that the 
assistance was inadequate to cover needs, and 73% reported additional income was needed to 
cover medical expenses. 
 Branching further out in terms of the social burden attributable to RDs, two studies 
mentioned the social economic costs of the specific diseases they focused on.  For patients with 
MFS, the excess annual costs from a societal perspective was €15,728 in comparison to a control 
individual.  This means that depending on prevalence, the overall societal economic impact 
ranges from €24 - €61.4 million, and makes the economic impact, in comparison to a patient 
with diabetes (costs adjusted), for the patient with MFS nearly six times higher than the impact 
per patient with diabetes (Achelrod, et al., 2014).  The social economic costs of DMD, per 
patient, per year were found to be $80,120 - $120,910, and these costs increased as the disease 
progressed (Landfeldt, et al., 2014). 
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Lack of Treatment Options & Medications 
 For patients with RDs, treatment options and medications are often severely lacking.  
Three studies addressed accessibility issues and one the risks that patients with RDs are willing 
to accept for treatment.  Anderson et al., found that Australian parents of children with RDs 
perceived a lack of access to important drugs that were currently being used overseas and not 
available for their own child’s benefit (2013).  US patients with HAE had to wait until 2008 and 
2009 for FDA approval of 2 very effective treatment options that had been available in European 
countries since 1979.  Although the costs of these two medications are expensive, presenting a 
financial issue, they are remedied by the positive impact they have in terms of reducing 
hospitalization costs, and missed time from work (Banerji 2013).  Another interesting 
characteristic seen in patients with RDs is the fact that they are willing to accept greater risks in 
their care, in hopes of finding an effective treatment, than patients of more common disorders.  
The same study also found that patients with RDs were frustrated with the costs of their 
treatments and care, as well as the lack of scientific data regarding treatments.  Notable concerns 
were mentioned about the development and testing of new treatments that could possibly be 
effective in treating their diseases and patients wanted these to occur as quickly as possibly in 
order to advance their QoL (Kesselheim., McGraw, Thompson, O'Keefe, & Gagne, 2014). 
Needs Experienced by Patients with RDs 
Information Needs 
 The need of information is an important topic for patients of RDs because of the lack of it 
and the internet has become a critical porthole for these patients due to the spread of its 
availability and accessibility.  In Denmark, 68% of patients with NET were active internet users 
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and had internet access and of those </= to 65 years, 95% had web access (Bager, Meyer, & 
Brandt, 2009).  Holtzclaw-Williams, et al., also found a high proportion (86.9%) of internet 
usage among U.S. patients with Alpha-1 antitrypsin (A1) (2013) and in the literature review by 
Zurynski, et al., the internet was found to be used by the majority of families for a variety of 
purposes related to RDs.  Because families need accurate and relevant information and 
advocation, as well as opportunities to interact with other families in similar situations, web-
portals have become a venue to provide families access to support groups and websites that have 
information on a variety of topics critical to patients with RDs (Zurynski, et al., 2008). 
Considering the recognized lack of it, patients of RDs were found to be accepting of 
information in a variety of different formats which may come from medical, non-medical, and/or 
internet sources.  Limb et al. found that patients and families were not given enough information 
on all aspects of their RD at diagnosis, or, subsequently over the course of their disease and that 
when information is provided, it needs to be available in a variety of formats and various levels 
of medical literacy to ensure patient understanding (2010).  The primary sources of information 
for patients with ED were 63% from support groups, 61% from internet sites, and 41% from 
specialists, with Pelentsov, et al. finding that 78% were satisfied with the information (2014).  
For patients with CHH, 96% had sought information online, however the internet, healthcare 
providers, and the online community were all ranked as equally important information sources.  
The CHH focus group participants showed that they were highly motivated internet users and 
overwhelmingly positive with regards to online interventions and support that would link them to 
expert healthcare providers as well as peer-to-peer support or other web-based interventions that 
might address their unmet needs (Dwyer, et al., 2014).  Patients with NET in Denmark expressed 
that there was a lack of internet information, and all internet users responded favorably to the 
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idea of it, with a majority (55%) actively searching webpages for NET information and wanting 
a Danish NET homepage (69%) (Bager, et al., 2009).  The study by Bager, et al., also found that 
there was a lack of written information for patients with NET in Denmark, with less than 50% 
being given sufficient written information by healthcare professionals, and only 2/3 of patients 
expressing they had received sufficient verbal information which came primarily from hospital 
doctors (2009).  Written information was also lacking for patients with HAE in that 13 of 16 UK 
medical centers treating HAE had patient leaflets about HAE, but only 4 had written patient 
information specifically for children and their carers, and only 5 were proactive about adding 
their patients to the European registry for HAE (Read, et al., 2014).  In terms of information 
needs changing, Gundersen, found that as parents move past getting a diagnosis for their child, 
and amassing information related to their child’s diagnosis, they tend to search for information 
regarding treatments, medications, and other aspects relevant to caring for a child with a RD.  
Parents noted that learning these facts helped them to shift expectations and accept their child’s 
challenges, and eventually, most of the parents significantly reduced their information-seeking 
activities (Gundersen, 2011). 
Information needs related to needs of research into RDs was another key theme for 
patients with RDs.  In the study of Australian children with metabolic disorders, 90% of parents 
wanted to keep abreast of the latest research and 73% wanted their children to participate in 
research studies (Anderson, et al., 2013).  In a study of over 600 patients and families with RDs 
Limb et al. found that patients were not well informed of research into their conditions, so that 
even if they were willing to be research subjects, there were low rates of participation in research 
studies.  Patient organizations were considered an important source of information on research 
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into the RD, and patients and families in this study were also generally appreciative of the 
importance of research and were willing to be involved in it (2010). 
Patient Support Groups as Information and Support Sources 
 As patient support and advocacy groups are frequently the only or main source of 
information for RD patients, they play an important role in the diagnosis, information-gathering, 
and social support aspects of the diseases (Limb, et al., 2010).  The majority of parents of 
children with RDs in Gundersen’s study felt that they benefitted from using online support 
groups to find information, while all of the parents in the study regarded social support from 
other parents in similar situations as essential for helping them cope with feelings of loneliness 
and uncertainty (2011).  Support groups and meeting other patients through them, were 
implicated as the biggest reason for a positive feeling related to their rare disorder for the patients 
with RDs in another study (Wallenius, et al., 2009).  With regards to support in living a child’s 
diagnosis of ED, the majority of parents reported that second to family, internet sites were one of 
most important sources (Pelentsov, et al., 2014).  In the online support groups for patients with 
Cystinosis (CS) and their parents, participants valued their connections to others with the RD and 
patients sought to provide support and mentorship to younger patients and their families.  Adults 
with CS pictured themselves as role models, but also as an example of the potential progression 
of the disability and noted that going or being public about one’s health carries certain social and 
emotional risks (Doyle, 2015).  For patients with A1, forming a ‘collective identity’ was a theme 
expressed by those in an A1 support group from the study by Holtzclaw-Williams, et al., and 
supported by the expression of specific emotions of support and validation towards other 
participants (2013).  The content of the support group’s chat room demonstrated that these 
patients are an inclusive group with adequate resources who are linked by information 
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technology and that feelings of isolation and powerlessness were suggested as reasons for 
motivation and involvement in the chat room.  67.7% of patients with A1 valued interaction with 
each other, stating that talking to other ‘Alphas’ was important and 76.4% believed they could 
help a newly diagnosied ‘Alpha.’  All chat room postings received responses indicating support 
or with referrals to knowledgeable leaders within organizations.  In terms of information gleaned 
from patient support organizations, 8.4% heard about A1 through a national organization or 
support group and 45.2% used these organizations for explanations, questions, and concerns 
about diagnosis, however 22.4% of family members did not want to be involved in support 
groups (Holtzclaw- Williams, et al., 2013). 
 Although patient support and advocacy groups are critical information and support 
resources to many patients with RDs, the notion that their existence is lacking for many patients 
with RDs is expressed by a number of the studies in this review.  A majority (57%) of parents in 
the Australian study by Anderson, et al. were interested or very interested in being involved with 
a peer support group, however less than half had found one in Australia.  37% of these parents 
had looked for a support group overseas and despite only 43% of families having been given 
information on support groups at diagnosis, 87% thought it should be routinely offered at this 
time (2013).  For patients in Denmark with NETs, Bager et al. found that there was a lack of a 
National Patient’s Association (NPA) and that 72% of patients with NET would welcome one.  
This interest was higher among internet users who comprised a significant majority of patients in 
the study.  69% of the patients with NET believed they would have benefitted from an NPA at 
the time of diagnosis, 72% would consider being members of an NPA (88% of internet users in 
the study), and 46% would be interested or possibly interested in an active role in an NPA (100% 
of internet users would take an active part in an NPA) (Bager, et al., 2009). 
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Need for Peer Support 
 Another theme touched on by couple of studies was the need of patients with RDs and 
their families for peer support.  In the study by Dellve, Samuelsson, Tallborn, Fasth, & Hallberg 
although most mothers and fathers (60% and 70%) of children with RDs perceived themselves as 
having good or fairly good overall support to cope with their life situation, more mothers than 
fathers perceived a poor social network in problems with their children and fathers reported 
higher support levels from their spouses than mothers did (2006).  Isolation from family and 
friends was a theme expressed by patients with A1 as a result of frustration that family and 
friends are unfamiliar with their RD (Holtzclaw-Williams, et al., 2013).  Lastly, parents of 
children with RDs reported a greater need of meeting others with the diagnosis, than the patient 
with the diagnosis did, however both expressed this need to meet others like them (Wallenius, et 
al., 2009). 
Impact on Patient with RD and Family 
Decreased Quality of Life 
 The QoL for patients with RDs and their caregivers is often substantially impacted as a 
result of their diseases.  Patients with HAE and DMD consistently reported poorer health-related 
QoL measurements than healthy counterparts, as did DMD caregivers who had lower, but less 
significantly so, scores (Banerji, 2013; Landfeldt, et al., 2014).  Two of the studies in the series 
used the EQ-5D index, a European scale that measures health status and outcome, in order to rate 
QoL.  For patients with SCA, the EQ-5D index score was .48, signifying a low healthcare QoL 
that was substantially influenced by the degree of severity of SCA (Lopez-Bastida, et al., 2008).  
ALS patients had an average EQ-5D index score of .18 which indicated a very low healthcare 
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QoL for these patients and was also significantly associated with the degree of severity of ALS 
(with QoL decreasing as the disease severity increased) (Lopez-Bastida, et al., 2009).  Using 
different measures, in which 100 is the best imaginable health status and 0 is the worst, Chevreul 
et al. found that patients with SS had an average score of 59, their caregivers 76, and that this 
was significantly lower than the general population as well as other diseases such as HIV or 
Type II Diabetes Mellitus (2014).  All patients with FCAS reported burdensome symptoms by 
the time they reached school age and 30% had symptoms that were limiting as infants or toddlers 
(Stych, et al., 2008).  In Cohen, & Biesecker’s systematic review of 58 QoL studies, the severity 
of the RD was correlated in some studies with a lower QoL, however this was found to be 
typically only with the physical dimensions of QoL.  Other studies in that series suggested that 
clinical severity was not correlated with QoL and that patients with milder severity had poorer 
QoL or that patients with more severe health issues had a higher QoL.  The central theme was 
that although genetic conditions have the potential to have significant negative consequences for 
the patients experiencing them, other factors besides physical manifestations, more psychological 
in nature, contributed to the overall QoL (2010). 
Impact on Daily Life 
 Patients with RDs were found to have a variety, of mostly negative, impacts on their 
daily life related to their RDs which must be managed on a long term basis.  In terms of daily 
functioning, children with genetic metabolic disorders in the Australian study averaged a score of 
4, which equates to some difficulty in a single area.  40% of the children in this series scored 5 or 
6, equating to variable problems in some or severe problems in one area, and 13% scored 7 or 8, 
meaning unable to function in almost all areas.  68% had significant pain and 36% had impaired 
hearing, speech, or communication (Anderson, et al., 2013).  In adult HM patients, where the 
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average QoL was found to be worse than for children with HM or HM patient caregivers,  75% 
were found to have physical problems with mobility, 40% had problems with self-care, 63.3% 
had problems with usual activities, and 76.7% had problems with pain and discomfort (Kodra, et 
al., 2014).  For FCAS patients, 90% experienced symptoms as newborns and 100% had 
symptoms before the age of 10.  Furthermore, the majority of patients with FCAS had symptoms 
in the severe range (5-7) for rash, joint pain, chills, and fever and 95% of them avoided outdoor 
activities as it aggravates their symptoms (Stych, et al., 2008).  In the study by Wallenius et al., 
the respondents with RDs reported needing to change their standard of living, needing travel 
services, personal assistants, home services, and 28% reported spending over 21 hours per month 
on personal care related to their rare diagnosis (2009).  In patients with HAE who go untreated, 
an average of one attack every 1-2 weeks is experienced, which lasts 2-5 days and varies in 
severity.  Pain associated with these attacks averages an 8.4 out of a 10 point scale, however 69% 
of patients report a pain level of 10.  These patients also have rates of mortality by asphyxiation 
as high as 40%.  Moderate symptoms that impacted ADLs were reported by 56%, while 28% 
reported severe symptoms that rendered them unable to perform ADLs (Banerji, 2013). 
 In addition to personal life, patients with RDs have problems that impact employment, 
educational, and social areas of life.  Work impairment was reported by 34% of patients with 
HAE causing an average of 3.3 missed days of work per attack and 57.5% believed it affected 
career advancement (Banerji, 2013).  Education issues were also reported by patients with HAE 
48.4% believing it hindered educational attainment and 30% requiring time off from school at an 
average of 1.9 days per attack (Banerji, 2013; Read, et al., 2014).  Zurynski, et al.’s literature 
review found that patients with RDs report isolation, stigmatization, and discrimination, as well 
as reduced educational and employment opportunities, and this is complicated by disrupted or 
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‘impossible’ schooling as over half of RDs are diagnosed in childhood (Zurynski, et al., 2008).  
In the Australian study, 70% of parents reported their child’s illness meant they saw friends and 
family less often (Anderson, et al., 2013).  Patients with HAE estimated they lose 20-100 days of 
social activities per year; 83% of patients with FCAS experienced disease-related issues with 
social activities including personal relationships; and 40% of patients with RDs reported minor 
to very big problems in contacts with the community (Banerji, 2013; Stych, et al., 2008; 
Wallenius, et al., 2009) 
Negative Impact on Psychosocial Health 
 The impact of psychosocial sequelae on the daily lives of patients with RDs is another 
important and often missed issue that is important to address for patients with RDs. Adult 
patients with HAE experienced depression at a rate of 42.5%, while pediatric patients with HAE 
had anxiety about the impact of HAE in daily life and functioning.  Because HAE attacks are 
unpredictable and impair a person’s ability to do work or perform ADLs, patients have 
heightened anxiety levels.  Their three biggest fears consist of 85% being sudden airway closure, 
65% being intolerable pain, and 55% passing HAE on to their children (Banerji, 2013; Read, et 
al., 2014).  Anxiety was also found to be an issue for 43% of patients with HM (Kodra, et al., 
2014).  Patients with CHH commonly had feelings of isolation and shame that were linked to 
body image concerns, low self-esteem, anxiety/depression, and the sense of feeling left behind 
peers developmentally as a result of the CHH and 15% had experienced discrimination because 
of it (Dwyer, et al., 2014).  For the 1660 patients with RDs in Wallenius et al.’s Swedish study, 
more than 70% of patients perceived emotional and social effects of their RD (2009).  Despite 
the negative effects of RD’s on patients, positive aspects were described by some study 
participants such as a change in their view of life, or that the experience had broadened their 
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minds (Wallenius, et al., 2009).  In Cohen et al.’s systematic review of patients with RDs, the 
individuals with higher levels of depression, anxiety, and psychological stress had poorer QoL, 
while a higher QoL was associated with factors such as psychological well-being, coping, illness 
perceptions, and family functioning.  The strongest predictors of QoL were found to be self-
esteem and illness perceptions which supports the idea that feelings and beliefs determined QoL 
even more than the rare disorders did.  Also reported by Cohen et al. was that individuals with 
more ‘negative’ attitudes tended to have poorer QoL while those who were more accepting, 
optimistic, hopeful, accepting of their disability and had a sense of coherence had a higher QoL 
(2010). 
Family Impact 
 The impact on a family of a child with a RD is far reaching with both positive and 
negative aspects, and significant parental psychosocial sequelae associated with it.  The level of 
family impact reported from the cohort of parents of children with RDs in Anderson, et al.’s 
study, was found to be 70% scoring significant impact, 20% scoring very serious impact, and 
notably, even for those who were considered to have superior or good health (the children with 
RDs), scoring a level that indicated at least moderate impact on the family.  Interestingly, finding 
reliable childcare for their child with a RD was reported as problematic by 77% of families 
(2013).  In the literature review by Zurynski, et al., in the U.S., 6% of patients with RDs had to 
move home and families reported being under-supported, over-burdened, and experiencing 
financial hardships.  Also, that mothers have significantly lower than average physical and 
mental well-being scores, and that QoL for siblings frequently suffers (Zurynski, et al., 2008).  
59% of parents of children with ED reported it impacted their other children, both positively and 
negatively, 36% said it impacted their relationship with their partner, both positively and 
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negatively, and 44% chose not to have any more children following the birth and diagnosis of 
their child (Pelentsov, et al., 2014). 
 A breadth of information exists regarding the psychosocial sequelae that occurs within 
families as a result of a child being diagnosed with a RD, with issues arising from information 
needs of parents reported in a portion of studies.  Griffith et al., reports that mothers feel 
unprepared and unsure about the future for their children because of the lack of information 
available to them on their child’s RD (2011).  The study by Gundersen illustrates the important 
role that information and knowledge play in the emotional well-being of parents who have a 
child with a RD because it allows them to manage and comprehend a stressful situation that at 
first seems unmanageable.  The study shows that becoming knowledgeable regarding a child’s 
condition is essential to this task and that parents use the internet as a way of ‘acting’ in order to 
cope with their emotions.  They report that ‘knowing’ (gaining information) was the basis on 
which parents could begin the emotional work of grieving and acceptance such that they could 
move on with their lives (Gundersen, 2011). 
 Stress and anxiety are some of the most commonly reported issues for parents of children 
with RDs and they come from a variety of sources related to parenting a child with a RD.  On a 
scale of 1-5, with 5 being the highest level of stress, 76% of parents in the study by Anderson, et 
al. scored a 3 or more, with 43% scoring a 4 or 5 (2013).  54% of parents of children with HM 
reported anxiety problems (Kodra, et al., 2014) and 92% of parents of children with ED reported 
a significant emotional response to having a child with ED (Pelentsov, et al., 2014).  Wallenius et 
al. found that the diagnosis of a RD causes stress on the whole family situation and that mothers 
in these families experienced high levels of stress (2009).  The psychological stress experienced 
by families and carers of children with RDs was reported in one study to be due social isolation, 
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unemployment, diagnostic delays, uncertainty about the future, lack of information, and 
difficulty with accessing appropriate health care (Zurynski, et al., 2008).  For parents of children 
with HAE fears and anxiety are related to long term funding of medications, availability of home 
therapy, and lack of awareness of HAE in schools and EDs (Read, et al., 2014).  A major stressor 
for parents in the Gundersen study are worries about their child and not knowing what the 
disorder might mean for the child’s prospects and prognosis, i.e. the stress of being confronted 
with an unknown destiny (2011). 
As for factors that influence positive family outcomes, a number of studies examined 
this.  In the systematic review by Cohen, et al., family functioning was found to significantly 
influence QoL, and that families with greater cohesion and a lower level of conflict had 
significantly higher QoL (2010).  Feeling closer because of the shared experiences of living with 
a child with a RD was reported by 70% of parents and 77% reported positive experiences with 
relatives because of it (Anderson, et al., 2013).  In the study by Dellve, et al. of children with 
RDs, more than 1/3 of parents had high levels of satisfaction in life and 60% were optimistic 
about the future.  Mothers reported that the most important factors related to life satisfaction 
were optimism about the future, spouse relationship problems, emotional demands, and social 
isolation, while fathers reported optimism about the future and perceived incompetence were 
most related to life satisfaction.  75% and 67% of fathers perceived themselves as having good or 
fairly good knowledge of how to handle everyday problems related to their child’s disability 
(Dellve, et al., 2006).   
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Discussion 
 The road to diagnosis for patients with RDs is exceedingly difficult and the results of this 
systematic review reiterate this point.  Delays in diagnoses in terms of years, multiple 
misdiagnoses, and having to see multiple physicians before receiving a correct diagnosis were 
found to be more common than not for patients with RDs.  Problems arising from misdiagnoses 
include unnecessary treatments, surgical procedures, and even death for some patients, which not 
only cause unnecessary pain and suffering for patients but unnecessary cost accrual for both 
patients and society.  In patients with a family history of RD, some of this burden of diagnosis 
was lifted, as parents and doctors were aware enough to know to test children, however this was 
not the case for most.  Another problem facing patients of RDs in trying to obtain a proper 
diagnosis is the need for travel to more knowledgeable specialists that takes patients to other 
regions, and sometimes other countries.  Communication issues complicated the delivery of the 
diagnosis with patients not being told about the genetic origin of their disease, about genetic 
counseling, or support groups which can be vital to coping with a RD.  Mixed results were seen 
in the satisfaction patients felt about how they were informed of their diagnosis with one study 
showing a majority being satisfied, while another showing close to a majority were not.  This 
inconsistency may be due to the differing countries and healthcare systems in which the studies 
were performed.  Furthermore, the importance with which patients placed on having a diagnosis 
for their RD was quite high as it has implications on management and provision of appropriate 
care of the RD, treatment, peace of mind, planning for the future, and reducing stress and anxiety 
for patients and parents of patients with RDs. 
 The lack of physician knowledge is another theme central to RDs.  Patients believe it 
contributes to the delays in diagnosis, as well as inadequate care and maltreatment.  This 
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insufficient expertise of physicians contributes to inconsistencies in specialized treatments for 
patients, with some doctors being aware of medications or other options while others are not, and 
at times patients must even inform their physicians about available options.  It is also a factor in 
patients undergoing multiple, unnecessary tests in order to reach a diagnosis, as is the fact that 
many RDs do not have treatment or diagnostic guidelines, or they are not updated in a timely 
manner.  Many times a lack of trust in physicians is a result of this knowledge shortfall.  It is 
heartening that physicians and other healthcare professionals are aware of this lack of awareness 
and knowledge related to RDs, however with the vast number of RDs it is impossible for any 
doctor to be proficient in diagnosing and/or treating them all.  To be able to get the right 
information to the right physicians (the ones treating patients of RDs), or a network that would 
allow better referrals to more knowledgeable physicians would be a key step in addressing this 
issue.  Although RDs remain to be under researched, this gap in information is becoming 
increasingly addressed with the development of research networks and patient registries 
(Zurynski, et. al, 2008) 
 Discrepancies in the relationship between patients with RDs and physicians is a factor in 
communication issues experienced by many patients with RDs and a result of a commonly 
experienced, yet atypical physician-patient relationship dynamic.  As patients of RDs are often 
forced to become the ‘expert’ in their disease, their knowledge may trump that of their doctors 
and thus a patient-directed interaction is a widely experienced pattern with RDs.  Unfortunately 
not all doctors are accepting of this style of interaction, yet strides could be made if more 
physicians acted as the patient’s partner in the medical encounter and supported them in their 
information seeking.  Because with RDs, the knowledge disparity often falls short on the 
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physician side, it requires a change of mindset away from traditional health care roles in order to 
remedy it. 
 In all of the studies in this review that touched on the topic of health services use, high 
levels were reported.  Patients with RDs had multiple hospital admissions, visits to physicians, 
specialists, and various therapists, and in comparison to a control group with more common 
diagnoses, longer lengths of hospital stays, more prescriptions, and medical imaging.  All of this 
extra medical care comes at a cost, both psychologically and financially as the patient is 
operating in ‘survival mode’ and it takes time and energy away from more fulfilling aspects of 
life.  It is hard to fully ascertain the implications of the lost sense of normalcy the patient 
experiences as a result of such frequent medical care. 
 Patients with RDs were found to commonly experience barriers in their quest to 
accessing appropriate healthcare.  These barriers include problems with physicians, travel 
distances required to see knowledgeable physicians, care coordination, medication and/or 
treatment access, and availability of or access to specialized treatment centers.  Uneven medical 
and social care provisions were implicated in inequitable access to treatments and treatment 
centers.  Other reported issues were the need for sibling care, the cost of services, the lack of 
services, lost time from work, lack of referrals, and long waits to see specialists or other doctors.  
All of these problems together or even one or a few of them is enough to thwart adequate care 
for a patient with a RDs.  Patients really liked the idea of multidisciplinary centers, however their 
low numbers continue to make them inaccessible to patients.  Patients also felt that their GP 
should coordinate their care, but in reality this does not happen to the extent that would be 
helpful and it would be a good intervention to further investigate in an effort to improve care. 
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 In the studies that investigated the provisions of social services for patients with RDs, 
more problems were found.  Even basic support services were lacking in some areas and 
combined with the complexity of using the system, if parents were unable to be strong advocates 
for their children they risked losing services or receiving inadequate ones.  Mothers were often 
left feeling like interactions with social services were ‘fights’’ and that they suffered physical 
and psychological impacts to their health as a result of them.  Pervasive problems such as abuse 
(25% of cases in one study) with day, respite, and residential services for patients with RDs also 
surfaced and caused limited trust in a service that is supposed to support people and families in 
need, and offer them respite. 
 In the studies examining costs associated with RDs, all found costs that were burdensome 
to patients.  Because of the nationalized healthcare systems in some of the countries, some costs 
for patients with RDs were alleviated, however there remained to be significant costs attributable 
to direct non-medical, and indirect needs of patients with RDs.  Medical costs related to 
hospitalizations, medications, and treatments were considerable in a number of the studies, 
however notably, costs associated with caregivers, including informal ones who lose wages or 
the opportunity to work, as well as costs associated with early retirement and lost time at work, 
were some of the biggest drivers in terms of expenses related to RDs.  These are not expenses 
covered by nationalized healthcare yet they pose a burden on the patient with the RD, the family, 
and society as a whole.  Other expenses related to RDs and placing an economic burden on 
society are those associated with educating a child with special needs (many children with RDs 
have disabilities), which is about double that of a healthy child, and those associated with social 
services.  The need for financial assistance in order to better support patients with RDs is clearly 
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evident and needs to be evaluated and remedied in a broader scope than the consideration of 
health services needs alone. 
 For patients with RDs, treatment options and medications are yet another problematic 
issue to be dealt with.  There is a known lack of accessibility to certain drugs because of 
regulations imposed by differing countries (i.e. an effective drug may be available in Europe, but 
not in the U.S. or Australia).  There is also an issue of lack of scientific data regarding treatments 
which presents a frustration to patients with RDs.  In lieu of this, an interesting finding was that 
patients with RDs were willing to take greater risks in their health care in hopes of finding 
effective treatments.  This is likely related to the fact that many RDs have high levels of 
morbidity and there are few if any treatment options for many of them.  All in all there is a great 
need for more research and better treatment options and medications for use in patients with 
RDs. 
 The need for information on a variety of topics related to a patient’s RD is another key 
component in the list of needs that patients with RDs have.  Overwhelmingly, the articles in this 
series reported on lack of information available to patients with RDs.  To their credit, these 
patients are especially determined and a high percentage have turned to the internet in search of 
that which their physicians cannot give them.  The internet and web-portals give patients the 
opportunity to find information related to their diseases, to treatment options, research, and very 
importantly support and knowledge from others with their same condition, whom they may have 
never in their life times have had the opportunity to meet.  Despite the usefulness of the internet 
in obtaining information for some, RDs were identified for which there was little or very lacking 
internet information and patients of these diseases wanted an online venue through which they 
could gain information and connect with others.  As such, the internet has proven to be a critical 
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tool in the quest for knowledge for many patients of RDs, however its continued growth in 
connecting patients to each other, health professionals and RD patients to better, more accurate 
information regarding RDs, and researchers to RD study participants would benefit even more 
patients with RDs as well as the health professionals involved in treating them. 
Even though the internet was found to be a helpful information source for some patients 
of RDs, the literature showed that patients were equally accepting of information from a variety 
of sources to include internet sites, specialists, online communities (which support RDs) and in 
both written and verbal forms.  Too often, patients with RDs reported not receiving satisfactory 
written or verbal information from their physicians, a sentiment that steered them to search the 
internet.  Of note, is the notion that as parents of RD patients move past seeking information 
related to getting a proper diagnosis and amass a greater understanding of their disease, their 
information needs change to seeking out treatment options, therapies, and medications that may 
be beneficial for their child.  Ultimately and foremost however, the biggest issue was and 
continues to be, the lack of information available regarding RDs and that patients of RDs are 
satisfied to receive it from any reliable source. 
 Research into RDs and the need for both dissemination of new research findings to 
patients of RDs and information regarding ongoing studies was another important topic for these 
patients.  Patients with RDs were found to be willing study participants given their higher than 
average risk tolerance for finding an effective treatment, and even the majority of parents of 
children with RDs wanted their child to participate in research studies if it were an option.  
Unfortunately, these ‘willing’ patients were not always well informed of new research studies to 
participate in and low rates of participation in research in research studies were observed.  This 
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gap could possibly be reduced by better information sharing and networking among support 
groups, researchers, and patient registries. 
 In the findings, the role of patient support and advocacy groups was that of a critical 
resource for patients with RDs.  These groups were implicated as essential for many patients in 
the diagnosing, information-gathering, and supportive aspects of their diseases.  These support 
groups allowed patients to cope with negative feelings and were even one of the biggest reasons 
for positive feelings related to the RD for some patients.  Next to family, many patients felt 
online support communities were one of the most important sources of support.  Patients also 
valued their connections with others with the same condition and sought to provide mentorship 
to younger patients and their families.  Some patients had concerns about the social and 
emotional risks associated with putting health information in a public format and while others 
hoped they were not negative examples of the future for younger patients because of the 
progression of certain diseases.  Despite the overall positive feedback from patients regarding 
RD support and advocacy groups, support groups for a number of diseases and in certain 
countries didn’t exist.  Of the patients without access to support groups surveyed, there was a 
high interest in them as well as a high desire for involvement.  This is an area of intervention 
where a significant impact could be made simply by patients helping other patients. 
 The need of support from peers was discussed in a couple of the articles.  Even when 
parents felt they had adequate coping skills, mothers perceived poor social networks as relevant 
to problems with their children, while fathers needed higher support levels from their spouses.  
Families felt frustration and isolation when friends and relatives were unfamiliar with their 
child’s diagnosis and both patients with RDs and parents of children with RDs reported a 
significant need of meeting others ‘like them.’ 
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 The overall QoL of patients with RDs was examined by multiple studies in this series.  In 
all of them, except for the systematic review by Cohen, et al., QoL suffered as a result of living 
with the diagnosis of a RD.  In two of the studies (SCA & ALS patients), QoL was directly 
correlated with severity of the disease and as the disease progressed, the QoL became poorer.  In 
light of this finding, it is critical to acknowledge that not all RDs have severe symptoms or 
progression to severe disability.  In Cohen’s systematic review specifically investigating the QoL 
for patients with RDs, clinical severity of a RD was not always associated with reduced QoL and 
in fact there were other, psychological, factors besides the physical manifestations that 
contributed to the perception of QoL.  This, in and of itself, presents a possible area of 
intervention, usurping physical ailments, through which Qol could be improved for patients with 
RDs. 
 The impact on daily life experienced by patients with RDs is another unavoidable burden 
for them to cope with.  Depending on the RD, these problems range from mild to severe, 
however many of the diseases captured in this review had notable daily problems.  These 
problems ranged from some to severe difficulty in daily functioning, even unable to function in 
nearly all areas and includes chronic paint that limited activities; impaired hearing, speech, 
and/or communication; physical mobility problems; and problems with self-care and usual 
activities.  In addition to problems experienced on a daily basis, patients with RDs had greater 
daily needs such as travel services, personal assistants, home services, changing their standard of 
living, and the increased time devoted to personal care related to their RD.  Employment, 
education, and socialization were among other daily challenges and all of the studies that 
explored these topics were found to have significant consequences in relation to missing work, 
school, or time with family.  These diseases ultimately create a burden that patients cannot 
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escape, turning each day into a struggle merely to get through, and thus it is understandable that 
psychosocial problems such as depression and anxiety are not uncommon in patients with RDs. 
 In the studies examining psychosocial issues related to RDs, negative as well as positive 
results were identified.  High levels of depression and anxiety were reported by a large 
percentage of patients, with a majority of patients in one study reporting emotional and social 
effects of their RD.  Other patients reported positive aspects of the RD such that it had changed 
their view of life and broadened their minds.  In the systematic review by Cohen et al., the 
patients with these higher levels of depression, anxiety, and psychological stress (i.e. more 
negative attitudes) had poorer QoL, while those who possessed psychological well-being, coping 
skills, and more positive illness perceptions and family functioning (i.e. more positive attitudes) 
were associated with higher QoL.  The implications of this are that the psychosocial sequelae so 
often experienced in patients with RDs can play a critical role in determining QoL. 
 The impact felt by a family when one of its members has a RD is undeniable.  Even when 
the symptoms of the RD are relatively mild, the family is unquestionably affected.  Parents tend 
to have high stress and anxiety levels that can affect their physical health as well as their 
relationships with each other and the QoL for siblings may suffer.  The diagnosis of a child with 
a RD is even the deciding factor for some parents not to have more children.  Lack of knowledge 
was related to higher stress and anxiety levels for parents, as it created uncertainty about the 
future.  However when parents felt knowledgeable about their child’s RD, they were better able 
to cope with the situation, and thus this role of information was essential to the process of 
grieving and acceptance so that they could move on and find their new ‘normal.’  A family’s 
functioning significantly influences QoL in that those families with less conflict and greater 
cohesion have higher QoL levels, however the mere management a child with a RD has the 
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potential to introduce situations for conflict.  Some families were brought closer as a result of the 
shared experiences of living with a child with a RD, while a majority of parents in another felt it 
create positive experiences with relatives and were optimistic about the future. 
Limitations 
 Combined, this review contains a wealth of information regarding the problems, needs, 
and impacts that patients with RDs and their families must deal with on a continual basis as well 
as a number of obvious limitations.  Although this review touches on long list of topics highly 
relevant to patients with RDs, the heterogeneity of the studies makes it difficult to draw succinct 
conclusions.  The studies included in this review come from a variety of countries that are not 
only culturally different, but have different health care systems, social systems and resources 
available to patients.  It is difficult to quantify costs across countries and disorders.  Another 
limitation is the fact that a variety of RDs are included and that these different diseases have a 
wide range of symptomologies and severities, which results in variance in the problems and 
needs expressed by the patients. It is also difficult with RDs to compile a large enough data set 
and a number of the included studies have small sample sizes, leaving a greater risk of error. 
Exploratory studies were used as were surveys, which are based on patient recall, and have the 
potential to be inaccurate.  Considering the breadth of this review, the actual numbers of articles 
touching on specific topics was limited for many topics, but it gives a long list of very relevant 
topics which could then be studied individually. 
Conclusion 
 Patients with RDs and their families are presented with numerous, confounding impacts 
on their daily lives and struggle with problems and needs not experienced by patients of other 
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diseases.  Because of their rarity, little is known about these diseases and resources to support 
them are often scarce.  One of the most critical problems patients with RDs experience is the 
difficulty and delays surrounding their diagnosis.  Optimal management of rare disorders begins 
with a timely and accurate diagnosis and this is the apex from which other issues snowball such 
as prompt and effective treatments to manage their dieases, and the ability to gain knowledge and 
plan for the future which has been shown to reduce fears and anxiety related to the experience of 
having a RD.  A diagnosis also gives patients the opportunity to join patient support groups 
geared towards their specific disease, where a wealth of information not available elsewhere can 
be found, as well as the peer and social support so critical to many of these patients. 
 Although it is known that patients with RDs and their families have heightened needs, 
and experience burdensome problems and impacts in their daily lives, there remains a great need 
for more research into these issues.  The ‘lack of information’ related to RDs is an umbrella 
under which most of the issues these patients experience could reside.  Many of the articles about 
the effects of RDs focus on only one, or a few, issues related to one disease and give us a small 
window into the issues and lives of these patients.  More research is certainly warranted and 
could be performed on any of the topics listed in this paper using a variety of RDs in order to 
obtain a better understanding of these issues across the board.  Patient advocacy groups are 
working hard to close these gaps and have been instrumental in raising awareness and research 
funding, however more needs to be done.  This would expand our knowledge surrounding RDs 
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Appendix 1 
Table 1: Research articles concerning the specific needs and problems faced by patients with rare disorders and their families 
Author & Year Country Purpose Type of 
Study 
Sample Measures Results: Topics of 
Problems, Needs, 
and Impacts of 
Rare Diseases on 
Patients and their 
Families 
Achelrod, et al, 
2014 
Germany To estimate excess 
societal and 
healthcare payer 
direct and indirect 










A Marfan syndrome group 
was constructed and 
compared with a non-Marfan 
Syndrome control group. A 
genetic matching algorithm 
was used in order to isolate 
causal effect of Marfan 
syndrome on excess costs 
and reduce differences in 
observable characteristics 
between Marfan syndrome 
patients and the control 
group. 
Health services use 
Costs 
 
Anderson, et al. 
2013 
Australia To develop a 
survey using 
validated tools to 
assess the scope 
and burden of the 
health, 
psychosocial, and 
financial impacts of 
caring for a child 













Survey questions were 
determined by using 
validated tools and questions 
were adapted from the 
EurordisCare surveys and 
the Australian Rett 
Syndrome survey, with 
additional questions 
constructed by the authors 
Diagnosis 
Lack of physician 
knowledge 
Health services use 
Barriers to accessing 
health services 
Impact on daily life 
Treatment options & 
medications 
Information needs 




THE BURDEN OF RARE DISEASES 
Bager et al., 
2009 








39 NET patients 
treated at Aarhus 
University 





population of 146 
NET patients 
treated at this 
hospital. 





information, and the 
estimated need for an NPA.  
Simple proportion analyses 
were used for all statistical 
analyses. 
Information needs 




Banerji, 2013 USA To review the 
literature on the 
burden of Illness 







11 articles Articles whose topics 
included diagnosis, 
symptoms, treatment, quality 
of life, and costs were 
included. 
Diagnosis 
Lack of physician 
knowledge 
Quality of Life 
Impact on daily life 
Psychosocial factors 
Treatment options & 
medications 
Budych, et al., 
2012 




patients with rare 
diseases and to 
explore these 
interactions and 






with patients with 








A series of semi-
standardized interviews with 
patients suffering from 6 
specific rare disorders that 
were recorded, transcribed, 
and analyzed thematically 
according to the grounded 
theory tradition. 
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Chevreul, et al., 
2014 
France To provide and 
analyze data on the 
economic burden 
and health-related 




in France.  To raise 
awareness of 
systemic sclerosis, 
it's burden for 
patients and 
caregivers and on 
the health and 

















and for patients 







Data on patients' use of 
resources were obtained 
from an online questionnaire 
retrospectively with costs 
estimated from a bottom-up 
approach.  HRQoL for 
patients and caregivers was 
assessed with a 5-level 
EURQoL-5 Dimension 
health questionnaire. 
Health services use 





Cohen, et al., 
2010 
USA To summarize and 
integrate research 
findings regarding 
quality of life 
(QoL) in in patients 





enhance the QoL of 







58 Quality of 
Life Studies 
Articles were chose via 
inclusion/exclusion criteria 
and those in question were 
discussed among the 
authors. 
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Dellve, et al., 
2006 





mothers and fathers 
of children with 
rare disabilities, 
and how these 
variables may be 












136 mothers and 
108 fathers of 
children with rare 
disabilities 
Instruments of parental 
stress, social support, self-
rated health, optimism, life-
satisfaction, and perceived 
physical or psychological 
strain were used with 
stratified analysis carried out 
for mothers and fathers and 
related to parental demands. 
Peer support 
Family impact 
Doyle, 2015 USA To explore the 
interaction of 
patients and 












their parents (21 
families total) 
Grounded theory approach Patient support & 
advocacy groups 
 
Dwyer, et al., 
2014 
Switzerland To determine if 
internet-based 
platforms were 
effective tools to 
conduct an online 
needs assessment 
survey; to identify 
unmet health and 
informational needs 








 Data was obtained using an 
online survey and patient 
focus groups and examined 
by descriptive statistics and 
thematic qualitative analysis. 
Lack of physician 
knowledge 
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EURORDIS, 
2007 
Europe To provide 
evidence on the 
delay in diagnosis 
in rare disorders 





6,000 rare disease 
patients 
Quantitative analysis  Diagnosis 
Feinberg, et al., 
2013 
Canada To use interview to 
better understand 
the patient 
experience of NET 
from the 
perspective of 













interviews with a qualitative 
approach to quide sampling, 
data collection, data 
analysis, and data synthesis 
Diagnosis 
Lack of physician 
knowledge 
Griffith, et al., 
2011 
UK To explore the 
mother's 
experiences of 
social care support 
and medical 
services for their 
adult offspring with 





syndrome, and Cri 










Lange, or Cri du 




Thematic content analsysis 
of a semi-structured 
interview 
Lack of physician 
knowledge 
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Gundersen, 
2011 
Norway To explore and 
analyze the 
experience of 10 
Norwegian parents 
whose children 
have different rare 
genetic disorders 
and how the 
internet can be a 









Qualitative interviews with 
an 'open approach' to explore 








Willams, et al., 
2013 
USA To support 
individuals 
impacted by a rare 
genetic disorder 
and to assess 
collective identity 





















reports from 2 
Alpha-1 
organizational 
websites, and 2 
separate online 
chat rooms for 
A1 patients 
Each data source was 
independently analyzed and 
then data and analyses were 
triangulated for 
completeness, convergence, 
and to confirm depth. 
Lack of physician 
knowledge 
Information needs 





USA To investigate the 
perspective of rare 
disease patients on 
the development 
and usage of 
possible treatments 





focus groups with 
a total of 26 rare 
disease patients 
Software was used to 
analyze the transcripts of the 
focus groups for common 
themes 
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Kodra, et al., 
2014 
Italy To investigate 
social burden, 
quality of life, and 









89 patients and 
17 caregivers of 
patients with 
Hemophilia A or 
B 
A questionnaire to gather 
information on 
demographics, healthcare 
and social services 
consumption, formal and 
informal care utilization, 
productivity, and quality of 
life (assessed through the 
EuroQoL).   
Health services use 




Kodra, et al., 
2007 
Europe To evaluate 
patients and 
caregivers opinions 
about the quality 
and accessibility of 






302 patients of 
various rare 
diseases 
Questionnaire analyzed with 
descriptive and comparative 
analysis 





International To obtain the total 
cost of illness and 











patients, 5 years 




UK, and US 
Data on health care, quality 
of life, work status, informal 
care, and household 
expenses was collected from 
patients and caregivers to 
estimate DMD costs from 
the perspective of society 
and caregiver households 
and analyzed for each 
country (Germany, Italy, 
UK, and US). 
Quality of Life 
Costs 
Limb, et al., 
2010 
UK To examine the 
struggles of daily 
life with a rare 
genetic conditions 
and to find out 
more about the 
experiences of 
living with a rare 





600 patients and 
families with rare 
diseases 
Quantitative and qualitative 
analysis 
Diagnosis 
Lack of physician 
knowledge 




Patient support & 
advocacy groups 
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and to identify 
common issues and 
problems they face 
Lopez-Bastida, 
et al., 2008 
Spain To determine the 
economic burden 
and health related 
quality of life 








84 SCA patients A retrospective assessment 
of resources obtained 
through questionnaires filled 
out by patients and/or the 
patient’s caregivers. The 
approach used was the cost-
of-illness study based on a 
societal perspective, and the 
EQ-5D generic 
questionnaire (QoL). 
Quality of Life 
Costs  
Lopez-Bastida, 
et al., 2009 
Spain To determine the 
economic burden 
and health related 
quality of life 









63 ALS patients A retrospective assessment 
of resources obtained 
through questionnaires filled 
out by patients and/or the 
patient’s caregivers. The 
approach used was the cost-
of-illness study based on a 
societal perspective, and the 
EQ-5D generic 
questionnaire (QoL). 




International To provide an in-
depth account of 
the experiences and 
supportive care 
needs of parents 







126 parents from 
14 countries 
Focus group data was used 
to  assist in the development 
of an internationally 






Patient support & 
advocacy groups 
Family impact  
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Read, et al., 
2014 














111 HAE patients 
and their 
parents/carers 
from 16 UK 
health centers 
with HAE 
patients; 10 out 
of 12 patients at 
one HAE center. 
QA questionnaire was sent 
to each center as well as a 2-
page questionnaire sent to 12 
patients at one center 
exploring the diagnosis, 
treatment, and impact on 
quality of life (QoL). 
Diagnosis 




Family impact  
Stych, et al., 
2008 
USA To get a better 
understanding from 
the patient's 
perspective of the 
disease and it's 








30 patients with a  
diagnosis of 
FCAS 
Patients from a FCAS data 
base were interviewed.  Both 
open-ended and response 
format questions and 
structured response format 
questions were asked.  
Symptom severity was rated 
on a scale of 1-7 with 7 
being the most severe and 1 
being the least. 
Diagnosis 
Quality of Life 








financial impact of 














Quantitative analysis with 
descriptive statistics 
Diagnosis 
Lack of physician 
knowledge 
Barriers to accessing 
health services 
Impact on daily life 
Psychosocial factors 
Costs 
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Zurynski, et al., 
2008 
International To address the 
impacts of rare 
diseases on 
patients, families, 
caregivers, and the 
community; the 
impacts of rare 
disease on 
clinicians and 
health services; and 
how governments 
responded to the 
need for health 
services, research 
and policies related 







36 articles Search of databases 
(Medline, The Cochrane 
Library, and Google) for 
articles containing 
information on the impacts 
of rare diseases on families, 
clinicians, health services 
and policies. 
Diagnosis 
Lack of physician 
knowledge 
Health services use 
Barriers to accessing 
health services 
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